From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 87665
Last updated 2014-11-24
Summary
The purpose of this study is to increase childhood influenza vaccination rates using the FDA licensed influenza vaccines according to national guidelines in a randomized cluster trial in which primary care offices are randomized to intervention or control with the control group receiving the intervention in the second year.
Conditions
Interventions
- BEHAVIORAL
-
4 Pillars Immunization Toolkit
Pillar 1: Convenient Vaccination Services; Pillar 2: Patient notification about the importance of vaccination and availability of convenient services; Pillar 3: Enhanced Office Systems; Pillar 4: Motivation: Office immunization champion tracks progress towards a goal; Early delivery of donated vaccines for disadvantaged children, staff education, support of effort by research staff.
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Richard Zimmerman, MD, MPH · University of Pittsburgh, School of Medicine, Department of Family Medicine and Clinical Epidemiology
-
Chyongchiou Lin, PhD · University of Pittsburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2013-02-28
- Completion
- 2013-11-30
Countries
- United States
Study Locations
More Related Trials
-
Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly
NCT02741843 ·Status: COMPLETED ·Phase: NA
-
Health Management Training to Enhance Influenza Vaccine Immunogenicity
NCT01256515 ·Status: COMPLETED ·Phase: NA
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Immunologic Response to Influenza Vaccination in Children and Adolescents
NCT03614975 ·Status: COMPLETED ·Phase: PHASE4
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Immune Response to Seasonal FluMist in Healthy Adults
NCT01673425 ·Status: TERMINATED ·Phase: NA
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
Improving Influenza Vaccination Rates Among Health Care Professionals
NCT00404664 ·Status: COMPLETED ·Phase: NA
-
Impact of Influenza Vaccination in Pregnancy Video Education
NCT02151201 ·Status: COMPLETED ·Phase: NA
-
The Effect of Time-Slot Scheduling on Flu Vaccination Rates
NCT01206686 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection
NCT00800605 ·Status: COMPLETED ·Phase: PHASE3
-
Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy
NCT04590066 ·Status: COMPLETED ·Phase: NA
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York
NCT02227186 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Safety of an Inactivated H5N1 Influenza Vaccine Administered in GelVac Nasal Powder to Healthy Young Adults
NCT01258062 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 Years
NCT01560793 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
NCT03599739 ·Status: COMPLETED
-
H5N1 Priming and Boosting Strategies
NCT00703053 ·Status: COMPLETED ·Phase: PHASE2